---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286798286.md"
description: "Brady shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 adjusted EPS guidance above estimates. Also, the company narrowed its FY26 GAAP EPS guidance above estimates."
datetime: "2026-05-18T15:57:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286798286.md)
  - [en](https://longbridge.com/en/news/286798286.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286798286.md)
---

# 

Brady shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 adjusted EPS guidance above estimates. Also, the company narrowed its FY26 GAAP EPS guidance above estimates.

### Related Stocks

- [BRC.US](https://longbridge.com/en/quote/BRC.US.md)

## Related News & Research

- [Brady forecasts $5.20-$5.30 adjusted EPS for fiscal 2026 as Honeywell PSS deal targets $0.80 accretion](https://longbridge.com/en/news/286800635.md)
- [Brady Q3 revenue rises on organic growth, acquisitions, raises FY adj. EPS outlook](https://longbridge.com/en/news/286760648.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [Calidi Biotherapeutics GAAP EPS of -$0.43](https://longbridge.com/en/news/286474175.md)
- [Earnings Scheduled For May 19, 2026](https://longbridge.com/en/news/286903624.md)